Effective Date October 6, 2023
Please note that International Healthcare Media, LLC (IHM) and its portfolio of brands, including Ophthalmology 360®, Med Journal 360™, and Rare Disease 360™, focus on reporting emerging technologies, techniques, and medical therapies. As a result, certain online reports, articles, videos, and other content may discuss drug and device applications that have not received regulatory approval or may not be considered standard medical practices.
It is important to emphasize that these articles are intended solely for informational purposes. They should not be used as the sole basis for patient treatment decisions. The opinions expressed by authors and quoted sources within the content are their own and do not necessarily reflect the opinions of IHM’s editors, publishers, or editorial boards.
Furthermore, the acceptance of advertising does not imply endorsement by IHM’s editors, publishers, or editorial boards. We appreciate your understanding.